Health in Paraguay 1,304 indicators covering health for Paraguay. IndicatorLatest Year10-yr change Rank Neonatal mortality rate - SDG 3.2.2 8.59 2024 down 28.9% 15th Prevalence of severe wasting, weight for height, female 0.2% 2016 up 100.0% 75th Prevalence of severe wasting, weight for height, male 0.5% 2016 unchanged 66th Prevalence of overweight, weight for height, female 11.9% 2016 up 60.8% 4th Prevalence of overweight, weight for height, male 13.0% 2016 up 106.3% 5th HPV immunization coverage estimates among primary target cohort (9-14) 42.0% 2025 down 46.2% 97th How many health warnings are approved by the law for cigarette 4 2022 up 300.0% 105th Tuberculosis - new and relapse cases 2,372 2011 up 14.4% 104th Diarrhea treatment 28.2% 2016 — 74th Pregnant women receiving prenatal care 98.7% 2016 up 4.8% 14th Coverage of the human papillomavirus vaccine 73 2024 down 15.1% 24th Average of 13 International Health Regulations core capacity scores 77.32 2017 down 6.8% 70th New cases: pulmonary smear-negative 221 2012 down 28.9% 121st Estimated number of pregnant women living with HIV needing 500 2025 unchanged 57th 3.3.1 (HIV Incidence) - New HIV infections per 1,000 uninfected 0.0316 2020 down 13.0% 69th Average death rate due to natural disasters 0.0766 2019 down 70.9% 98th Number of full-time equivalent staff in national agency 0 2022 down 100.0% 138th Total number of notified TB cases 2,415 2014 down 4.9% 105th The number of people with susceptibility test result for rifampicin 1,639 2021 — 56th Estimated number of pregnant women living with HIV 68 2025 up 15.3% 58th Number of deaths caused by intentional injuries 1,107 2021 up 29.2% 14th Mortality rate 4.02 2024 down 15.8% 14th Neonatal deaths 0.5272 2024 down 2.5% 23rd Mother-to-child HIV transmission rate 19.6 2024 up 9.5% 27th New cases: pulmonary smear unknown/not done 273 2012 down 41.4% 39th Smear-positive tuberculosis treatment-success rate 78.0% 2011 up 8.3% 108th Share of one year olds who received the rotavirus vaccine 80 2024 down 11.1% 60th Insufficiently active 83.48 2016 down 0.6% 77th The number of people with susceptibility test result for rifampicin 92.7 2021 — 60th Contraceptive prevalence, any method 52.8% 2016 up 4.5% 16th Number of presumed malaria cases 0 2024 — 40th Contraceptive prevalence, any modern method 51.4% 2016 up 22.7% 12th Number of indigenous malaria cases 0 2024 — 82nd Number of confirmed malaria cases 2 2024 down 75.0% 98th Total number of malaria cases 2 2024 down 75.0% 98th Retreatment cases: treatment after default 53 2012 down 77.7% 66th Yellow fever vaccine (YFV) immunization coverage among 1-year olds 83.0% 2025 down 10.8% 10th Number of indigenous P. falciparum malaria cases 0 2024 — 75th Number of suspected malaria cases 10,777 2024 up 61.2% 95th Retreatment cases: other 138 2012 down 38.9% 64th Retreatment cases: treatment after failure 16 2012 up 433.3% 84th Number of malaria positive cases by microscopy 2 2024 down 75.0% 90th Unmet need for contraception 12.1% 2016 up 83.8% 40th Number of malaria suspects examined by microscopy 10,768 2024 up 61.0% 87th Absolute number of deaths from ambient particulate air pollution 1,600 2015 up 14.3% 122nd Natural disasters deaths 0 2016 — 7th Tuberculosis funding versus budget requirement 3.81 million 2025 up 16.0% 44th Preterm birth rate 7.81 2020 up 3.0% 51st Preterm birth 10,828 2020 up 9.3% 57th Antenatal care attendees who were positive for syphilis (%), reported 4.6% 2024 up 306.1% 6th Percentage of people living with HIV who have suppressed viral loads 52 2025 up 23.8% 73rd Percentage of people living with HIV receiving treatment who have 87 2025 up 2.4% 78th Antenatal care coverage - at least four visits 82.1% 2023 up 7.0% 50th Number of cases of cutaneous leishmaniasis reported 50 2024 down 59.7% 44th Number of victims of intentional homicide - SDG 16.1.1 477 2024 down 17.5% 18th Proportion of the population with positive out-of-pocket household 21.1% 2023 up 3.1% 25th Number of cases of visceral leishmaniasis reported 61 2024 down 48.3% 18th Exclusive breastfeeding 29.6% 2016 up 35.1% 58th Laboratories providing tuberculosis diagnostic services using culture 9.9 2014 up 130.2% 38th Number of malaria positive cases by rapid diagnostic test 2 2024 up 100.0% 80th ← Previous Page 20 of 22 Next →